Nikang Therapeutics, Inc.
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2017-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.nikangtx.com
A Study with NKT3964 for Adults with Advanced/Metastatic Solid Tumors
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2024-11-13
- Lead Sponsor
- NiKang Therapeutics, Inc.
- Target Recruit Count
- 90
- Registration Number
- NCT06586957
- Locations
- 🇺🇸
Florida Cancer Specialists & Research Institute, Lake Mary, Florida, United States
🇺🇸Sarah Cannon Research Institute (SCRI), Nashville, Tennessee, United States
🇺🇸John Theurer Cancer Center at Hackensack UMC, Hackensack, New Jersey, United States
A Study With NKT3447 for Adults With Advanced/Metastatic Solid Tumors
- Conditions
- Interventions
- First Posted Date
- 2024-02-20
- Last Posted Date
- 2024-10-10
- Lead Sponsor
- NiKang Therapeutics, Inc.
- Target Recruit Count
- 90
- Registration Number
- NCT06264921
- Locations
- 🇺🇸
University of California San Francisco (UCSF) - Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States
🇺🇸The Gabrail Pharmacology Phase 1 Research Center, Canton, Ohio, United States
🇺🇸Texas Oncology-Austin Midtown NEXT Oncology, Austin, Texas, United States
Ph2 Study NKT2152 with Palbociclib & Sasanlimab in Subjects with Advanced Clear Cell Renal Cell Carcinoma (ccRcc)
- Conditions
- Interventions
- First Posted Date
- 2023-07-07
- Last Posted Date
- 2024-10-31
- Lead Sponsor
- NiKang Therapeutics, Inc.
- Target Recruit Count
- 172
- Registration Number
- NCT05935748
- Locations
- 🇺🇸
University of California San Diego, La Jolla, California, United States
🇺🇸Northwestern University - Feinberg School of Medicine, Chicago, Illinois, United States
🇺🇸Dana-Farber Cancer Institute, Boston, Massachusetts, United States
A Study of NKT2152, a HIF2α Inhibitor, in Patients with Advanced Clear Cell Renal Cell Carcinoma
- First Posted Date
- 2021-11-15
- Last Posted Date
- 2024-10-16
- Lead Sponsor
- NiKang Therapeutics, Inc.
- Target Recruit Count
- 128
- Registration Number
- NCT05119335
- Locations
- 🇺🇸
HonorHealth, Scottsdale, Arizona, United States
🇺🇸UCLA, Los Angeles, California, United States
🇺🇸Sarah Cannon Research Institute, Denver, Colorado, United States